Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SBRT”

1,192 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,192 results

Early research (Phase 1)Study completedNCT00567970
What this trial is testing

Stereotactic Radiation Therapy in Treating Patients With Liver Metastases

Who this might be right for
Metastatic Cancer
Mayo Clinic 9
Large-scale testing (Phase 3)Active Not RecruitingNCT03367702
What this trial is testing

Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer

Who this might be right for
Stage II Prostate Adenocarcinoma AJCC v7
NRG Oncology 692
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07817095
What this trial is testing

SBRT Combined With Reduced-Dose Anthracycline Chemotherapy and Toripalimab as Neoadjuvant Therapy for Localized High-Risk Undifferentiated Pleomorphic Sarcoma

Who this might be right for
Undifferentiated Pleomorphic Sarcoma (UPS)
Tianjin Medical University Cancer Institute and Hospital 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT03654131
What this trial is testing

Microwave Ablation Versus Stereotactic Body Radiotherapy for Colorectal Liver Metastases in Oligometastatic Disease: a Prospective, Randomised, Phase 2 Trial

Who this might be right for
Colorectal CarcinomaLiver Metastases
Rigshospitalet, Denmark 100
Not applicableStudy completedNCT01540994
What this trial is testing

Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer

Who this might be right for
Prostatic Neoplasm
Sharp HealthCare 12
Early research (Phase 1)UnknownNCT05185531
What this trial is testing

Neoadjuvant Tislelizumab With SBRT in Patients With Resectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shandong Cancer Hospital and Institute 20
Testing effectiveness (Phase 2)UnknownNCT04921995
What this trial is testing

Immunotherapy and Chemotherapy in Unresectable Recurrent Loco-regionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Recurrent Nasopharyngeal CarcinomaUnresectable Nasopharyngeal CarcinomaChemotherapy Effect+2 more
Fudan University 40
Testing effectiveness (Phase 2)UnknownNCT04165174
What this trial is testing

PD-1 Monoclonal Antibody Plus Apatinib Combined With SBRT in HCC With PVTT

Who this might be right for
HCC
Huazhong University of Science and Technology 20
Not applicableEnded earlyNCT03984019
What this trial is testing

Cardiac Changes After Stereotactic Radiotherapy for Early Stage NSCLC Cancer or Lung Metastasis

Who this might be right for
Lung Cancer Stage ILung Cancer Stage IILung Metastases
The Netherlands Cancer Institute 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05500092
What this trial is testing

An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer

Who this might be right for
Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
Montefiore Medical Center 17
Testing effectiveness (Phase 2)Looking for participantsNCT06323239
What this trial is testing

SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 148
Testing effectiveness (Phase 2)Ended earlyNCT00938457
What this trial is testing

Stereotactic Radiation Therapy in Treating Patients With Liver Metastases

Who this might be right for
Unspecified Adult Solid Tumor
Mayo Clinic 3
Not applicableLooking for participantsNCT04863612
What this trial is testing

SBRT in the Management of Solid Spinal Metastases

Who this might be right for
Extradural TumorSpinal Metastases
Universitaire Ziekenhuizen KU Leuven 100
Testing effectiveness (Phase 2)Study completedNCT03595644
What this trial is testing

Maintenance Targeted Therapy With or Without Stereotactic Body Radiation Therapy for Stage IV Non-small Cell Lung Cancer

Who this might be right for
Stage IV Non-small Cell Lung Cancer
Tongji Hospital 74
Not applicableStudy completedNCT01620034
What this trial is testing

Lung Stereotactic Body Radiotherapy (SBRT) Delivered Over 4 Days Versus 11 Days

Who this might be right for
Peripherally Located Stage I Lung CancerPeripherally Located Solitary Lung Metastasis
Sunnybrook Health Sciences Centre 50
Not applicableUnknownNCT03326375
What this trial is testing

Comparison of SBRTand Repeat TACE for HCC

Who this might be right for
HepatoCellular Carcinoma
Gangneung Asan Hospital 80
Not applicableActive Not RecruitingNCT04081428
What this trial is testing

Using Breath, Cell Free DNA and Image Analysis to PRedIct Normal TissUe and Tumour Response During Prostate Cancer SBRT

Who this might be right for
Prostate CancerRadiotherapy Side EffectsVolatile Organic Compounds+1 more
NHS Lothian 60
Testing effectiveness (Phase 2)UnknownNCT06040177
What this trial is testing

Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular Carcinoma Non-resectablePortal Vein Tumor ThrombusImmune Checkpoint Inhibitors
First Affiliated Hospital of Guangxi Medical University 30
Not applicableLooking for participantsNCT06293157
What this trial is testing

Carbon Fiber Transpedicular Screws in Treatment of Spinal Metastatic Disease

Who this might be right for
Metastatic Spinal Cord CompressionMetastasis Spine
Copernicus Memorial Hospital 226
Not applicableUnknownNCT02145286
What this trial is testing

Phase 1/2 Study to Determine Optimal Dose for Treating Bone Metastases Using Novel STAT-RT Workflow

Who this might be right for
Metastatic Bone Lesion
Paul W. Read, MD 47
Next Page